Unknown PHASE4 INTERVENTIONAL 2-arm NCT05109000

Comparison of Subcutaneous Injection of Normal Saline and Bacteriostatic Saline

Clinical Effects of the Subcutaneous Injection of 10ml of Normal Saline and Bacteriostatic Saline: A Double-Blind Randomized Clinical Trial

Sponsor: Jeffrey Alan Klein, MD

Conditions Anesthesia, Local Benzoic Acid Adverse Reaction Injection Site Bruising Injection Site Discomfort Injection Site Irritation

Interventions Bacteriostatic Sodium Chloride 0.9 % INJECTION VIAL (ML) Sodium Chloride 0.9% Inj

Updated 4 times since 2021 Last updated: Oct 25, 2021 Started: Nov 30, 2021 Primary completion: Jan 31, 2022 Completion: Jan 31, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Anesthesia, Local and Benzoic Acid Adverse Reaction and is currently ongoing. Jeffrey Alan Klein, MD leads this study, which shows 4 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Nov 2023 — Jul 2024 [monthly]

Unknown Status PHASE4

Status: Not Yet Recruiting → Unknown Status
Dec 2021 — Nov 2023 [monthly]

Not Yet Recruiting PHASE4

First recorded

Nov 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Jeffrey Alan Klein, MD

Data source: HK Surgical, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• San Juan Capistrano, United States